Holen Sie sich die Stockscreener-App
4.75
1.06%
0.05
Handel nachbörslich:
4.64
-0.11
-2.32%
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc(SPRC) Stock Options Chain | Quotes & News - Moomoo
SciSparc Ltd. (Nasdaq: SPRC) starts Phase IIb SCI-110 trial for Tourette - Stock Titan
NeuroThera starts Phase IIb trial in Germany fo... - Pluang
SciSparc Subsidiary NeuroThera Initiates Phase IIb SCI-110 Clinical Trial Site at Hannover Medical School for Adult Tourette Syndrome - Quiver Quantitative
Tourette treatment candidate SCI-110 enters testing at Hannover Medical School - Stock Titan
NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome - TheNewswire
SciSparc (SPRC) Slips Over 7%: Support at $4.11 in Focus After Sharp DeclineWeak Sell Signals - dars.gov.et
SciSparc Ltd. (SPRC) details Alon Dayan RSUs and option in ownership update - Stock Titan
SciSparc Ltd. (SPRC) revises director Revach Moshe’s share and RSU holdings - Stock Titan
SciSparc Ltd. (SPRC) director details RSU and option holdings in Form 3/A - Stock Titan
SciSparc Ltd. (SPRC) director revises Form 3, detailing RSU and option holdings - Stock Titan
SciSparc Ltd. (SPRC) CTO clarifies 5,528 RSU-linked shares and option terms - Stock Titan
SciSparc Ltd. (SPRC) director amends Form 3, details 3,649-share stake - Stock Titan
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
SciSparc (SPRC) Surges Over 10% as Trading Activity Picks UpOrder Block - dars.gov.et
SPRC Stock Price, Quote & Chart - ChartMill
NeuroThera Labs Announces Upsize to Private Placement - TheNewswire
NeuroThera Labs Announces C$5,000,000 Private Placement of Units - TheNewswire
SciSparc (SPRC) Drops 6.7% as Shares Approach Critical Support ZoneETF Creation Redemption - dars.gov.et
SciSparc Company Profile & Introduction - Moomoo
Scisparc Ltd (SPRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Form 144 SciSparc Ltd. For: 22 June By Investing.com - Investing.com Australia
[144] SciSparc Ltd. SEC Filing - Stock Titan
SciSparc (SPRC) Suffers Sharp Decline: Key Support Levels Under PressureVolume Breakout Ideas - dars.gov.et
Scisparc Ltd (SPRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Scisparc Ltd (SPRC) Institutional Confidence - TradingKey
Scisparc Ltd (SPRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scisparc Ltd (SPRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
SPRC News | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Scisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scisparc Ltd (SPRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Scisparc Ltd (SPRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scisparc Ltd (SPRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SciSparc Ltd. (SPRC) Slips 2.46% as Shares Test Near-Term Support at $7.92Composite Profile - dars.gov.et
SciSparc Ltd. Ordinary Shares Stock Short Interest Rises to 66.94% - Moomoo
SciSparc Ltd.'s Equity Buyback announced on July 7, 2022, has expired. - marketscreener.com
Why is SciSparc stock skyrocketing on Thursday? - MSN
SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal - MSN
NeuroThera completes acquisition of 54% stake in CliniQuantum - Investing.com UK
In today's session, these stocks are experiencing unusual volume. - ChartMill
Which stocks are gapping on Thursday? - ChartMill
SPRC Stock Pops As SciSparc Pushes Into Quantum Clinical Analytics - timothysykes.com
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum - TipRanks
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
NeuroThera completes acquisition of 54% stake in CliniQuantum By Investing.com - Investing.com India
SciSparc (NASDAQ: SPRC) unit NeuroThera acquires 54% of CliniQuantum in CAD$9.46M share deal - Stock Titan
Quantum trial-analysis startup CliniQuantum sold in C$9.5M SciSparc deal - Stock Titan
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Completes Acquisition of 54% Stake in CliniQuantum Ltd. - Quiver Quantitative
NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. - Yahoo Finance
Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - marketscreener.com
SciSparc's Quantum Gambit: Betting on AI to Remake Drug Trials - BriefGlance
Director Itschak Shrem Sells Shares of SciSparc Ltd (SPRC) - GuruFocus
SciSparc (SPRC) director Itschak Shrem sells 462 Ordinary Shares at $10 - Stock Titan
SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline - Bez Kabli
1.50%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):